Skip to main content

HYPOTHESIS AND THEORY article

Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 16 - 2024 | doi: 10.3389/fnagi.2024.1482255
This article is part of the Research Topic CSF Clearance in Alzheimer's Disease and Related Dementias: Exploring Mechanisms and Implications View all 3 articles

Nasal lymphatic obstruction of CSF drainage as a possible cause of Alzheimer's disease and dementia Shortened title: Nasal CSF obstruction in Alzheimer's disease

Provisionally accepted
  • 1 The University of Texas Health Science Center at San Antonio, San Antonio, United States
  • 2 Methodist Hospital, San Antonio, Texas, United States

The final, formatted version of the article will be published soon.

    Alzheimer's disease, the most common form of dementia among older adults, slowly destroys memory and thinking skills. In recent years, scientists have made tremendous progress in understanding Alzheimer's disease, still, they don't yet fully understand what causes the disease. This article proposes a novel etiology for Alzheimer's disease. Our hypothesis developed from a review of nuclear medicine scans, in which the authors observed a significant increase in nasal turbinate vasodilation and blood pooling in patients with hypertension, sleep apnea, diabetes and/or obesity, all risk factors for Alzheimer's disease. The authors propose that nasal turbinate vasodilation and resultant blood pooling lead to the obstruction of normal nasal lymphatic clearance of cerebrospinal fluid and its waste products from the brain. The nasal turbinate vasodilation, due to increased parasympathetic activity, occurs alongside the well-established increased sympathetic activity of the cardiovascular system as seen in patients with hypertension.The increased parasympathetic activity is likely due to an autonomic imbalance secondary to the increase in worldwide consumption of highly processed food associated with dysregulation of the glucose regulatory system.The authors' hypothesis offers a novel mechanism and a new paradigm for the etiology of Alzheimer's disease and helps explain the rapid worldwide rise in the disease and other dementias which are expected to double in the next 20 years. This new paradigm provides compelling evidence for the modulation of the parasympathetic nervous system as a novel treatment strategy for Alzheimer's disease and other degenerative brain diseases, specifically targeting nasal turbinate lymphatic flow.

    Keywords: Dementia, parasympathetic activity, glymphatics, tau, Amyloid, Alzheimer's disease, metabolic syndrome, CSF drainage

    Received: 17 Aug 2024; Accepted: 09 Oct 2024.

    Copyright: © 2024 Phillips and Schwartz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: William T. Phillips, The University of Texas Health Science Center at San Antonio, San Antonio, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.